Dhanvantri Jeev. (531043)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹19.95 |
| Market Cap | ₹8.19 Cr |
| P/E Ratio | 83.67 |
| ROCE | 5.82% |
| ROE | 1.87% |
| Dividend Yield | 0% |
| Profit Growth | 13.33% |
| Debt/Equity | — |
| Sales Growth | 27.54% |
| 52-Week Range | ₹19.53 — ₹30 |
| Sector | Healthcare Services |
| Book Value | ₹24.75 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹19.95, Dhanvantri Jeev is a microcap healthcare services company with a market capitalization of just ₹8 crore. The first thing that catches my eye is the balance sheet: book value is ₹24.75, so the stock trades at only 0.81 times book. Benjamin Graham taught us to look for a margin of safety, and on assets alone, this seems to offer one. But I have to ask whether those assets are productive. The numbers say no—ROE is a weak 1.87% and ROCE is just 5.82%. The latest quarter shows sales of ₹7 crore but net profit of essentially zero, so the business is not generating meaningful earnings today.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer